Mackean P. Maisha
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Mathematical Statistician/Biostatistician
Also affiliated: United States Food and Drug Administration (2014–2024); Center for Drug Evaluation and Research (2016)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Mackean P. Maisha's research focuses on toxicological studies, particularly investigating the dose-response relationships and long-term effects of various chemical compounds in animal models and human patient samples. Recent work includes assessing the toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats and conducting inhalation toxicity studies of NNK, a nitrosamine, in the same rat model. Maisha also investigates genotoxicity by examining erythrocyte PIG-A mutant frequencies in cancer patients undergoing cisplatin treatment. Further research includes a two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice. Maisha has published 12 papers, accumulating 221 citations and an h-index of 7. Key collaborators include Robert P. Felton, Robert H. Heflich, Mason G. Pearce, and Ralph E. Patton, all from the National Center for Toxicological Research, with whom Maisha has co-authored multiple publications.
Metrics
- h-index: 7
- Publications: 12
- Citations: 240
Positions
-
Mathematical Statistician/Biostatistician 2013–presentNational Center for Toxicological Research/US FDA OSC/Division of Bioinformatics & Biostatistics ORCID
-
Biometric Consulting lab/Graduate Research Assisitant 2006–2010University of North Carolina at Chapel Hill Gillings School of Global Public Health Biostatistics ORCID
-
Biostatistician 2001–2004Harvard School of Public Health Center for Biostatistics in AIDS Research (CBAR) ORCID
Selected Publications
-
Erythrocyte PIG‐A mutant frequencies in cancer patients receiving cisplatin (2024)
-
Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice (2023)
-
Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats (2022)
-
90-day nose-only inhalation toxicity study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Sprague-Dawley rats (2021)
-
14-Day Nose-Only Inhalation Toxicity and Haber’s Rule Study of NNK in Sprague-Dawley Rats (2021)
-
Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach (2019)
-
A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results (2019)
-
An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma (2019)
-
An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability (2018)
-
In Vivo Monitoring of Sevoflurane-induced Adverse Effects in Neonatal Nonhuman Primates Using Small-animal Positron Emission Tomography (2016)
-
Positron Emission Tomography with [18F]FLT Revealed Sevoflurane-Induced Inhibition of Neural Progenitor Cell Expansion in vivo (2014)
Collaboration Network
Top Collaborators
- A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- 14-Day Nose-Only Inhalation Toxicity and Haber’s Rule Study of NNK in Sprague-Dawley Rats
- 90-day nose-only inhalation toxicity study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Sprague-Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- 14-Day Nose-Only Inhalation Toxicity and Haber’s Rule Study of NNK in Sprague-Dawley Rats
- 90-day nose-only inhalation toxicity study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Sprague-Dawley rats
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- Stability of the Human Plasma Proteome to Pre-analytical Variability as Assessed by an Aptamer-Based Approach
- An Integrated Analysis of Metabolites, Peptides, and Inflammation Biomarkers for Assessment of Preanalytical Variability of Human Plasma
- An Aptamer‐Based Approach to Assess the Human Plasma Proteome for Pre‐Analytical Variability
- A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results
- 14-Day Nose-Only Inhalation Toxicity and Haber’s Rule Study of NNK in Sprague-Dawley Rats
- 90-day nose-only inhalation toxicity study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Sprague-Dawley rats
- A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results
- Toxicity of high-molecular-weight polyethylene glycols in Sprague Dawley rats
- Two-year dermal carcinogenicity bioassay of triclosan in B6C3F1 mice
- A two-year toxicology study of bisphenol A (BPA) in Sprague-Dawley rats: CLARITY-BPA core study results
- 14-Day Nose-Only Inhalation Toxicity and Haber’s Rule Study of NNK in Sprague-Dawley Rats
- 90-day nose-only inhalation toxicity study of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Sprague-Dawley rats
Similar Researchers
Based on overlapping research topics